182 related articles for article (PubMed ID: 9862166)
1. 99mTc-labeled chimeric anti-NCA 95 antigranulocyte monoclonal antibody for bone marrow imaging.
Sarwar M; Higuchi T; Tomiyoshi K; Inoue T; Oriuchi N; Kbalil A; Alyafei S; Sakahara H; Chung JK; Endo K
Radiat Med; 1998; 16(5):391-7. PubMed ID: 9862166
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
Ivancevic V; Huic D; Wolter A; Munz DL
Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders.
Chung JK; Yeo J; Lee DS; Park S; Lee MC; Kim BK; Koh CS
J Nucl Med; 1996 Jun; 37(6):978-82. PubMed ID: 8683326
[TBL] [Abstract][Full Text] [Related]
4. Different biodistribution of 99mTc-labelled chimeric mouse-human monoclonal antibody between athymic mice model and human.
Oriuchi N; Watanabe N; Sugiyama S; Higuchi T; Imai K; Yamanaka H; Hashimoto M; Kanda H; Endo K
Br J Cancer; 1996 Jun; 73(12):1466-72. PubMed ID: 8664114
[TBL] [Abstract][Full Text] [Related]
5. Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody.
Choi CW; Chung JK; Lee DS; Lee MC; Chung HK; Kim BK; Koh CS
Nucl Med Biol; 1995 Jan; 22(1):117-23. PubMed ID: 7735161
[TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy of the bone marrow: normal uptake values of technetium-99m-labeled monoclonal antigranulocyte antibodies.
Huić D; Ivancević V; Richter WS; Munz DL
J Nucl Med; 1997 Nov; 38(11):1755-8. PubMed ID: 9374347
[TBL] [Abstract][Full Text] [Related]
7. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
Krause T; Reinhardt M; Nitzsche E; Moser E
Nuklearmedizin; 1999 Apr; 38(3):85-9. PubMed ID: 10320994
[TBL] [Abstract][Full Text] [Related]
8. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.
Gratz S; Behr T; Herrmann A; Dresing K; Tarditi L; Franceschini R; Rhodes B; Stürmer KM; Becker W
Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168
[TBL] [Abstract][Full Text] [Related]
9. 99Tcm-labelled chimeric human/mouse anti-granulocyte antibody bone marrow scintigraphy: a preliminary clinical study.
Higuchi T; Inoue T; Sarwar M; Oriuchi N; Karasawa M; Naruse T; Yamanaka H; Watanabe T; Chung JK; Endo K
Nucl Med Commun; 1998 May; 19(5):463-74. PubMed ID: 9853336
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent difference in biodistribution of monoclonal antibodies in animal models and humans.
Oriuchi N; Watanabe N; Kanda H; Hashimoto M; Sugiyama S; Takenoshita S; Imai K; Ueda R; Endo K
Cancer Immunol Immunother; 1998 Aug; 46(6):311-7. PubMed ID: 9756415
[TBL] [Abstract][Full Text] [Related]
11. In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammation.
Joseph K; Höffken H; Bosslet K; Schorlemmer HU
Eur J Nucl Med; 1988; 14(7-8):367-73. PubMed ID: 3181186
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.
Kotzerke J; Glatting G; Seitz U; Rentschler M; Neumaier B; Bunjes D; Duncker C; Dohr D; Bergmann L; Reske SN
J Nucl Med; 2000 Mar; 41(3):531-7. PubMed ID: 10716329
[TBL] [Abstract][Full Text] [Related]
14. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of accumulation of 99mTc-sulesomab in inflammation.
Skehan SJ; White JF; Evans JW; Parry-Jones DR; Solanki CK; Ballinger JR; Chilvers ER; Peters AM
J Nucl Med; 2003 Jan; 44(1):11-8. PubMed ID: 12515870
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosis.
Thelen MH; Eschmann SM; Moll-Kotowski M; Dopfer R; Bares R
J Nucl Med; 1998 Jun; 39(6):1033-5. PubMed ID: 9627340
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow imaging of bone marrow transplanted multiple myeloma patients.
Agren B; Rudberg U; Måre K; Aspelin P
Clin Nucl Med; 1997 Feb; 22(2):80-92. PubMed ID: 9031764
[TBL] [Abstract][Full Text] [Related]
18. [99mTc-labelled antigranulocyte anibody fragment Fab scintigraphy (sulesomab, leukoscan) and three-phase bone scintigraphy in the study of painful hip and knee prosthesis].
Jiménez Heffernan A; Contreras Puertas PI; Rebollo Aguirre AC
Rev Esp Med Nucl; 2002 Jul; 21(4):286-93. PubMed ID: 12206742
[TBL] [Abstract][Full Text] [Related]
19. Targeting NCA-95 and other granulocyte antigens and receptors with radiolabeled monoclonal antibodies (Mabs).
Meller J; Liersch T; Oezerden MM; Sahlmann CO; Meller B
Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):582-98. PubMed ID: 21221067
[TBL] [Abstract][Full Text] [Related]
20. Effect of tumor mass and antigenic nature on the biodistribution of labeled monoclonal antibodies in mice.
Watanabe Y; Endo K; Koizumi M; Kawamura Y; Saga T; Sakahara H; Kuroki M; Matsuoka Y; Konishi J
Cancer Res; 1989 Jun; 49(11):2884-9. PubMed ID: 2470499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
